Ophthalmology Times Europe

ADVERTISEMENT

  • home
  • about us
  • contact us
  • subscribe
  • media kit request
 

CATARACT

GLAUCOMA

REFRACTIVE

RETINA

ADVERTISEMENT

Previous StoryPlay / PauseNext Story
Latest cataract news
Local anaesthesia for cataract surgery
January 6, 2010
A comparative evaluation of local anaesthesia for cataract surgery, published in The Journal of Cataract & Refractive Surgery says that randomized clinical trials are needed to facilitate statistical methods of metaanalysis to establish convincingly the overall benefits and efficacy of the various local anesthesia procedures in cataract surgery.
Ketolorac tromethamine should be available in September
August 19, 2009
Allergan Inc. expects its ketorolac tromethamine ophthalmic solution 0.45% (Acuvail) to be available in the United States in September. The preservative-free formulation of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the treatment of pain and inflammation after cataract surgery and received FDA approval at the end of July, the company announced.
Researchers uncover genetic link to age-related cataracts
August 19, 2009
Researchers in Cleveland have discovered the first gene associated with the formation of age-related cataracts. EphA2 encodes an enzyme that plays a role in the repair of proteins in the lens of the eye after they become damaged and clump together, according to the investigators.
Clinical trials show promise to help mydriasis during cataract surgery
August 19, 2009
Results from the Omeros Corporation for the Phase I/Phase II clinical trial of OMS302, a proprietary combination of an anti-inflammatory agent and an agent that causes pupil dilation (mydriasis) are said to be promising.
Post cataract surgery pain treatment gets thumbs up
August 5, 2009
ACUVAIL (Allergan), the ketorolac tromethamine ophthalmic solution, which acts as a treatment for inflammation and pain after cataract surgery has been approved by the FDA.
Cataract articles
Premium IOL options
For compromised, and potentially compromised eyes.
Multifocal IOL a succesfful option
FDA results and personal experience demonstrate very high satisfaction with lens
A new method for easier enclavation of iris-claw IOLs
The VacuFix technique has been introduced to fix the Artisan and Artiflex IOLs in a fast, precise and reproducible way.
Do personality characteristics impact multifocal IOL patient satisfaction
First answers from the Happy Patient Project
Visual performance of a new multifocal diffractive IOL
Comparative study shows excellent intermediate vision results, high levels of spectacle independence and minimal photic phenoma at night.
Newsletter sign-up
CO-MICS special report: part 1
Coaxial microincision cataract surgery: the future is small
CO-MICS special report: part 2
Special feature asks the question: is the future small?
Survey
Would you use corneal cross-linking to treat infectious fungal keratitis?
Yes
No
Yes
50%
No
50%
Call for papers

Click here to discover how you can have your say

Click here